Median lobe destruction apparatus and method

US11504149B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11504149-B2
Application numberUS-201916562806-A
CountryUS
Kind codeB2
Filing dateSep 6, 2019
Priority dateMay 20, 2005
Publication dateNov 22, 2022
Grant dateNov 22, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A system and associated method for altering or destroying tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders. In one aspect, the system includes a device configured to deploy devices for altering the lobes of a prostate.

First claim

Opening claim text (preview).

We claim: 1. A method for treating benign prostatic hypertrophy, comprising: assessing an anatomy of a median lobe; inserting a treatment device within a urethra, the treatment device includes an extendable needle and an elongate member; advancing the treatment device into an ejaculatory duct; actuating the treatment device to advance the needle within the median lobe; and manipulating the elongate member to capture, separate, cut, dissect and/or remove tissue of the median lobe. 2. The method of claim 1 , wherein the elongate member is advanceable through the needle. 3. The method of claim 2 , further comprising advancing the elongate member through and beyond the needle. 4. The method of claim 1 , further comprising applying energy to the median lobe to destroy tissue. 5. The method of claim 4 , wherein the energy is microwave energy. 6. The method of claim 1 , further comprising cauterizing median lobe tissue. 7. The method of claim 1 , further comprising applying a vacuum to remove tissue from the median lobe. 8. The method of claim 1 , wherein the elongate member includes a rotatable helical blade, further comprising rotation of the helical blade. 9. The method of claim 1 , wherein the elongate member includes a curved cutting blade and further comprising manipulating the curved blade to cut median lobe tissue. 10. The method of claim 1 , wherein the elongate member includes articulating cutting arms and further comprising articulating the arms to cut median lobe tissue. 11. The method of claim 1 , wherein the elongate member includes an expandable cutter and further comprising expanding the cutter to cut median lobe tissue. 12. The method of claim 1 , wherein the elongate member is a blunt dissector and further comprising dissecting median lobe tissue with the dissector. 13. The method of claim 12 , wherein the blunt dissector further includes a cutter blade. 14. The method of claim 1 , wherein the elongate member includes a ligature and further comprising configuring the ligature about the median lobe. 15. A method for treating benign prostatic hypertrophy, comprising: assessing an anatomy of a median lobe; inserting a treatment device within a urethra; advancing the treatment device into an ejaculatory duct; actuating the treatment device to advance a cutting device within a bladder neck; and cutting bladder neck and/or soft tissues surrounding the bladder neck. 16. The method of claim 15 , further comprising relaxing an opening of the bladder neck so that space is created to permit an increased luminal opening at the bladder neck.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11504149B2 cover?
A system and associated method for altering or destroying tissues and anatomical or other structures in medical applications for the purpose of treating diseases or disorders. In one aspect, the system includes a device configured to deploy devices for altering the lobes of a prostate.
Who is the assignee on this patent?
Teleflex Life Sciences Ltd
What technology area does this patent fall under?
Primary CPC classification A61B17/3205. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).